Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
LOS ANGELES, Aug. 7 /PRNewswire-USNewswire/ -- A new drug delivery system that uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a more effective method for the sustained delivery of medicines for retinal and vitreous disea...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that R788 (fostamatinib disodium) produced significant clinical improvement in rheumatoid arthritis (RA) patients in the recently completed TASKi2 Phase 2b clinical trial of ...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
PALO ALTO, Calif., June 15 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals' (Nasdaq: JAZZ ) sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last we...
FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
ROCKVILLE, Md. , June 8 /PRNewswire-FirstCall/ -- Attached is a press release issued yesterday by GlaxoSmithKline (GSK), regarding new Phase 2 data for Syncria(R) (albiglutide) presented at the American Diabetes Association 69th Scientific Sessions in New Orleans.
Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
Pre-heparinization Limits Clot Retention and Decreases Residual Clot Volume
SAN FRANCISCO, June 8 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administ...
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly redu...
Back to Normal: Surgery Improves Outcomes for Spine Patients
New study finds patients who opt for surgery have decreased pain, increased function
ROSEMONT, Ill., June 1 /PRNewswire-USNewswire/ -- People with the spine disease called degenerative spondylolisthesis * -- who choose surgical treatment -- experience substantially greater relief f...
New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings
U.S.D.A. Animal Studies: Chromium Picolinate and Chromium Histidinate Down-regulate Gene in Brain that Precedes Alzheimer's Disease
Additional Studies Continue to Demonstrate Safety and Efficacy of Nutrition 21's Chromax Chromium Picolinate
PURCHASE, N.Y., May 14 /PRNewswire-FirstCall/ -...
New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
AZTEC Trial First to Examine AZOR Using 24-Hour Ambulatory BP Measures
PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that data presented at the American Society of Hypertension, Inc. (ASH) Twenty-Fourth Annual Scientific Meeting and Exposition (ASH 2009) in San ...
Program Improves Language Skills in Deaf, Hard of Hearing
CINCINNATI, May 5 /PRNewswire-USNewswire/ -- Children enrolled before they are six months old in a home-based program that teaches language skills to the deaf or hard of hearing are not only able to achieve appropriate language skills but also to maintain them over time, according to a new study. ...
Brain Training Improves Memory and Attention and the Effects Last
CHICAGO, May 1 /PRNewswire/ -- Older adults can improve memory and attention by training on computerized brain exercises according to study data presented today at the annual meeting of the American Geriatrics Society in Chicago. Elizabeth Zelinski, PhD, lead investigator on the study and a profes...
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies
SAN MARINO, Calif., Nov. 20 /PRNewswire/ -- Epeius Biotechnologies
announced today the results of Phase I/II and II studies of Rexin-G in
chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as
presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th
Vascular Surgeons Agree: Case Rehearsal Improves Outcomes
CLEVELAND, Ohio and LOD, Israel, November 12 /PRNewswire/ -- Surgeons
at the University of Rochester Medical Center, NY indicated that
patient-specific CTA data can be converted to an endovascular simulator
(ANGIO Mentor(TM), Simbionix US) with high face validity. The surgeons
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
First Clinical Study of Paliperidone ER in this Under-Studied Condition
SAN DIEGO, Nov. 1 /PRNewswire/ -- Patients with schizoaffective
disorder receiving paliperidone extended release tablets (paliperidone ER)
for six weeks showed a significant improvement in their symptoms, according
to a ne...
Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
BOSTON, Oct. 15 /PRNewswire-FirstCall/ -- Perceptive Informatics, one
of the industry's leading eClinical technology providers and a subsidiary
of PAREXEL International Corporation (Nasdaq: PRXL ), announced today that
it has enhanced its TrialWorks(R) solution, a specialized Clinical Trial
TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
- Multicenter study finds unique combination of micronutrients superior to
current 'AREDS' standard of care; Results supported by new omega-3 study -
HOUSTON, Sept. 10 /PRNewswire/ -- A landmark study at five
university-based research centers found that TOZAL(R), a patented
combination of anti...
96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
PALO ALTO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Varian, Inc.
(NasdaqGS: VARI) announced today its new filtration plate for sample
preparation. Captiva(TM) NDLipids is a simple to use, non-drip 96-well
plate specially designed to remove phospholipids including
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
MONTPELLIER, France, September 1 /PRNewswire/ -- The ERATO study
published today in the American Heart Journal demonstrated, for the first
time in patients with permanent atrial fibrillation, that dronedarone
(Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of
'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
Findings in rats show promise for 'buying time' in victims of lethal hemorrhage
SEATTLE, July 1 /PRNewswire/ -- For the first time, researchers have
demonstrated that the administration of minute amounts of inhaled or
intravenous hydrogen sulfide, or H2S -- the ...
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Study Meets Primary Endpoint, with Positive Effect Sustained Through Duration of 4-Week Study
ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals
Inc. (Nasdaq: VNDA ) (Vanda) today announced positive top-line results from
a Phase III trial showing ...
Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
New Data Highlights the Need for Testosterone Screening in At-Risk Hypogonadal Men
BEDMINSTER, N.J., June 17 /PRNewswire/ -- New data from a 12-month,
international, multi-center study showed that treatment for low
testosterone with Tostran(R), a topical, metered ...
Abbott's Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
TriLipix in Combination with CRESTOR (rosuvastatin calcium) Demonstrates Similar Lipid Effects in Patients with Diabetes and Overall Study Population
SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- New data from a
sub-group analysis of patients with mixed dyslip...
New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
- Data From Phase 3 Study Presented at ASCO -
COLLEGEVILLE, Pa., May 31 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced results
of a three-arm phase 3 clinical trial that show patients with relapsed
and/or refractory mantle cell ...
CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest
Study published in Archives of Internal Medicine supports use of Q-CPR(TM) technology to improve CPR quality
ANDOVER, Mass., May 26 /PRNewswire-FirstCall/ -- Royal Philips
Electronics (NYSE: PHG , AEX: PHI) today announced the results of a study
confirming the benefit of usin...
CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
New Data Underscore the Utility of CAPHOSOL in Treating Oral Mucositis
PRINCETON, N.J., May 21 /PRNewswire/ -- New data show that CAPHOSOL(R)
(http://www.caphosol.com ), an advanced electrolyte solution, relieves painful oral
mucositis (OM) and improves
quality of life for cancer patients un...
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
- Trial Results Confirm Efficacy for Population Most Affected by Disease -
WAYNE, N.J. and EMERYVILLE, Calif., May 16 /PRNewswire-FirstCall/ --
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.
(Nasdaq: ONXX ) today announced that Nexavar(R) (sorafenib) tablets
AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
-Specific biomarkers for molecular tumor grade and endocrine benefit offer better prediction of individual patient outcome-
SAN DIEGO, May 13 /PRNewswire/ -- AviaraDx, Inc. today announced the
publication of an article describing the discovery, development and
validation of a new mol...
Ceremed's OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
LOS ANGELES, May 13 /PRNewswire/ -- New soluble polymer material
designed to stop bone bleeding in surgery improves
bone fusion and healing,
according to a new animal study just published in the Annals of Thoracic
Surgery (ATS). The findings come on the heels of recently published
Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
Phase III Data Presented at American Psychiatric Association Annual Meeting
WASHINGTON, May 7 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
(NYSE: FRX ) announced today that study results show Lexapro (escitalopram
oxalate) significantly improved symptoms of depression as compared to
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
Patients' Vision Improved from Detecting Hand Movements to Reading
Lines on Eye Chart
PHILADELPHIA, April 27 /PRNewswire-USNewswire/ -- In a clinical trial
at The Children's Hospital of Philadelphia, researchers from The University
of Pennsylvania have used gene therapy to safely restore...
SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine
Restored sensitivity to cisplatin observed in ovarian carcinoma xenografts
DUBLIN, Calif., April 14 /PRNewswire-FirstCall/ -- SuperGen Inc.
(Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery, rapid
development and commercialization of therapies for solid tumors and
Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
- Clinical evidence for unique Ranexa(R) mechanism of action -
CHICAGO, March 31 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
(Nasdaq: CVTX ) announced today that ranolazine significantly (p<0.001)
shortened the QT interval of patients with a hereditary form of long QT
Tailored Clopidogrel Dosing Improves PCI Outcomes
Blood test monitors each patient's response to anti-clotting drug
CHICAGO, March 29 /PRNewswire/ -- Using a simple blood test to
individualize the loading dose of a medication that prevents blood clotting
significantly reduces the risk of major cardiovascular complications after
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Company Also Announces Receipt of Fast Track Designation from FDA,
Favorable Scientific Advice from EMEA and Phase 3 Plans for the Non-Small Cell Lung Cancer Monotherapy Indication
SANTA MONICA, Calif., Feb. 26 /PRNewswire/ -- Dr. Giuseppe Giaccone,
Chief of the Medical Onco...
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
- Human Genome Sciences' ABthrax(TM) shows lifesaving potential -
- HGS on track to deliver 20,000 doses to Strategic National Stockpile beginning in 2008 -
ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Human Genome
Sciences, Inc. (Nasdaq: HGSI ) today annou...
TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
Data from Pivotal Study Show Bendamustine Produced a Significant Increase in Overall Response Rate and Progression Free Survival
FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) announced today that in a pivotal study of treatment-naive patients
with chronic ...
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
- First Study to Demonstrate Survival Benefit with ERBITUX in Patients with Colorectal Cancer Refractory to All Approved Chemotherapies -
NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- ImClone Systems
Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb Company (NYSE: BMY )
announced today r...
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
-- Major study of more than 2,100 patients with hip fracture shows
significant 35% reduction in subsequent osteoporotic fractures with Reclast -- Results published in The New England Journal of Medicine show
significant 28% reduction in overall mortality seen in study patients ...
Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
BROOMFIELD, Colo., Aug. 29 /PRNewswire/ -- Accera, Inc. announced today
that recent data from a Phase II study of its lead compound Ketasyn(TM)
(AC- 1202) in age-associated memory impairment (AAMI) showed that Ketasyn
has a positive and clinically meaningful effect on memory in older adults. ...
Once Daily, Extended-Release Ropinirole Improves Parkinson's
Symptoms in Patients not Optimally Controlled With Levodopa
'Off' Time Reduced By an Average of More Than Two Hours Per Day
RESEARCH TRIANGLE PARK, N.C., April 02, 2007 /PRNewswire/ --
Adding the once daily, investigational medication REQUIP(R)
(ropinirole HCl) XL 24-Hour(TM) Extended-Release Tablets to
Parkinson's patients' existing levodopa (L-dopa) ther...